Trial Parameters
Condition Bladder Cancer
Sponsor Photocure
Study Type OBSERVATIONAL
Phase N/A
Enrollment 4,400
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2014-04
Completion 2028-12
Interventions
Hexaminolevulinate hydrochloride (HCL)Karl Storz D-Light C Photodynamic Diagnostic (PDD) system
Brief Summary
Registry study to gather more information on the current use of Blue Light Cystoscopy with Cysview (BLCC) in urologists' practices.
Eligibility Criteria
Inclusion Criteria: * Adult \>18 years old * Suspected or known non-muscle invasive bladder cancer on the basis of a prior cystoscopy Exclusion Criteria: * Porphyria * Gross hematuria * Known hypersensitivity to hexaminolevulinate or aminolevulinate derivatives
Related Trials
NCT04574960
Neoadjuvant Upper Tract Invasive Cancer Trial (NAUTICAL)
View Trial →
NCT06775977
Ultrasound Contrast-Enhanced Accurate Diagnosis of Preoperative Staging of Bladder Cancer
View Trial →
NCT07090499
A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
View Trial →